Results 231 to 240 of about 7,144,441 (302)
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Author Correction: Building new hydrography and virtual watersheds to conserve freshwater fisheries. [PDF]
Benda L +4 more
europepmc +1 more source
Enemy's arsenal backfires: pathogen proteases detonate broad-spectrum plant immunity via engineered NLRs. [PDF]
Liu S, Jing Y, Chen J.
europepmc +1 more source
Differential Transdiagnostic Relevance of Early Maladaptive Schemas Across Personality Traits and Psychopathological Symptoms. [PDF]
Major J, Matuz A, Gács B, Birkás B.
europepmc +1 more source
Integrating Precision Sepsis Risk Stratification Into Systems-Based Antimicrobial Stewardship. [PDF]
Ford JS +4 more
europepmc +1 more source
The broad societal value of pembrolizumab for women's cancer in Canada. [PDF]
Brook E +7 more
europepmc +1 more source

